Insider · CIK 0001420766

Nicholson John

Reports to the SEC for 1 company · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001420766

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-08-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−3,819 sh	$18.15	−$69.3K	162,759
2019-05-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−4,077 sh	$31.37	−$128K	166,578
2019-02-19	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−3,822 sh	$42.39	−$162K	170,655
2019-01-28	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	+63K sh	$10.69	+$673K	237,477
2019-01-28	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−63K sh	$42.82	−$2.7M	174,477
2019-01-28	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	−63K sh	$10.69	−$673K	0
2018-11-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−5,982 sh	$38.25	−$229K	174,477
2018-08-16	NKTRNEKTAR THERAPEUTICSD Disposition to Issuer	SVP & Chief Operating Officer	DDisposition to Issuer	−8,137 sh	$58.40	−$475K	180,459
2018-08-15	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Operating Officer	AAward	+26K sh	—	—	188,596
2018-08-15	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Operating Officer	AAward	+65K sh	—	—	65,000
2018-05-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−4,917 sh	$83.39	−$410K	162,596
2018-03-07	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−100K sh	$100.45	−$10.1M	167,513
2018-03-06	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−120K sh	$98.29	−$11.8M	267,657
2018-02-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−4,879 sh	$82.94	−$405K	387,657
2018-01-31	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	+120K sh	$11.34	+$1.36M	392,536
2018-01-31	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	−120K sh	—	—	0
2017-12-15	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Operating Officer	AAward	+26K sh	—	—	272,536
2017-12-15	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Operating Officer	AAward	+65K sh	—	—	65,000
2017-11-16	NKTRNEKTAR THERAPEUTICSD Disposition to Issuer	SVP & Chief Operating Officer	DDisposition to Issuer	−6,620 sh	$44.23	−$293K	246,536
2017-11-15	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Operating Officer	AAward	+20K sh	—	—	253,156
2017-11-15	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Operating Officer	AAward	+50K sh	—	—	50,000
2017-11-13	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	+25K sh	$9.24	+$231K	249,066
2017-11-13	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−15.9K sh	$37.78	−$601K	233,156
2017-11-13	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	−25K sh	—	—	0
2017-08-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−3,177 sh	$19.32	−$61.4K	224,066
2017-06-07	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	+150K sh	$6.34	+$951K	328,943
2017-06-07	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−102K sh	$19.24	−$1.96M	227,243
2017-06-07	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	−150K sh	—	—	0
2017-05-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−3,146 sh	$19.55	−$61.5K	178,943
2017-02-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−3,237 sh	$13.14	−$42.5K	182,089
2017-02-10	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	+45K sh	$4.65	+$209K	185,326
2017-02-10	NKTRNEKTAR THERAPEUTICS · Employee Stock Option (right to buy)M Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	−45K sh	—	—	0
2017-02-03	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	+8,505 sh	$4.65	+$39.5K	148,831
2017-02-03	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−8,505 sh	$12.48	−$106K	140,326
2017-02-03	NKTRNEKTAR THERAPEUTICS · Employee Stock Option (right to buy)M Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	−8,505 sh	—	—	45,000
2017-02-02	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	+66.5K sh	$4.65	+$309K	206,821
2017-02-02	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−66.5K sh	$12.38	−$823K	140,326
2017-02-02	NKTRNEKTAR THERAPEUTICS · Employee Stock Option (right to buy)M Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	−66.5K sh	—	—	53,505
2016-12-13	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Operating Officer	AAward	+20K sh	—	—	140,326
2016-12-13	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Operating Officer	AAward	+50K sh	—	—	50,000
2016-11-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−1,654 sh	$13.96	−$23.1K	120,326
2016-08-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−3,317 sh	$17.56	−$58.2K	121,980
2016-07-14	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Operating Officer	AAward	+26K sh	—	—	103,630
2016-07-14	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Operating Officer	AAward	+87.5K sh	—	—	87,500
2016-07-14	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Operating Officer	AAward	+22K sh	—	—	22,000
2016-06-01	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Operating Officer	AAward	+100K sh	—	—	100,000
2016-05-17	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−856 sh	$13.58	−$11.6K	77,630
2016-05-16	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Operating Officer	MExercise/Conversion	+2,167 sh	$0.00	+$0.217	78,486
2016-05-16	NKTRNEKTAR THERAPEUTICS · Restricted Stock UnitD Disposition to Issuer	SVP & Chief Operating Officer	DDisposition to Issuer	−2,167 sh	—	—	21,667
2016-02-17	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Operating Officer	SSale	−963 sh	$11.92	−$11.5K	76,319

Recent filings

Accepted (ET)
Aug 194
Nicholson John0001209191-19-046718
SEC(opens sec.gov)
May 174
Nicholson John0001209191-19-031188
SEC(opens sec.gov)
Feb 214
Nicholson John0001209191-19-012335
SEC(opens sec.gov)
Jan 304
Nicholson John0001209191-19-006044
SEC(opens sec.gov)
Nov 194
Nicholson John0001209191-18-059293
SEC(opens sec.gov)
Aug 164
Nicholson John0001209191-18-047242
SEC(opens sec.gov)
May 184
Nicholson John0001209191-18-031596
SEC(opens sec.gov)
Mar 84
Nicholson John0001209191-18-018221
SEC(opens sec.gov)
Feb 204
Nicholson John0001209191-18-011595
SEC(opens sec.gov)
Feb 24
Nicholson John0001209191-18-007139
SEC(opens sec.gov)
Dec 194
Nicholson John0001209191-17-066481
SEC(opens sec.gov)
Nov 174
Nicholson John0001209191-17-061594
SEC(opens sec.gov)

Companies

NEKTAR THERAPEUTICSSVP & Chief Operating OfficerNKTR

Address

C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD

SAN CARLOS, CA, 94070